Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02528773 · ClinicalTrials.gov registry record
Efficacy of ART to Interrupt HIV Transmission Networks
A clinical trial of HIV, sponsored by University of California, San Diego.
- Completed
- Registry status
- 256
- Enrollment target
- 1
- Study location
NCT02528773 is a study of HIV that has completed, run by University of California, San Diego. The registered enrollment target is 256 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02528773, a study of HIV, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a study to learn more about the spread of HIV infection within different geographic regions and populations in San Diego County, with the goal of demonstrating that early use of HIV treatment can reduce the number of new infections in our community. At the study visits, participants will be examined by the study staff and asked to donate some blood. Participants will also be asked several questions about themselves, their background, behaviors, health, and the general geographic area in which they live. By collecting information about antiretroviral treatment choices that are made by study participants, the investigators will be better able to measure how effectively HIV treatment can interrupt (i.e., block) the spread of HIV. All of the information gathered at the study visits will be de-identified and analyzed. Study staff will use the information to better understand in which groups of people, and in what areas of San Diego, HIV is spreading most quickly. This information will be used to determine how well Antiretroviral Therapy (HIV treatment) by certain individuals can control the spread of HIV within the population.
Conditions Studied
Study Locations (1)
California
- UCSD AntiViral Research Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2014-09-09 |
| Est. Completion | 2020-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02528773
The ClinicalTrials.gov registry entry for NCT02528773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 0 interventions.
NCT02528773 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02528773 about?
NCT02528773 is a clinical study titled "Efficacy of ART to Interrupt HIV Transmission Networks". The investigators are conducting a study to learn more about the spread of HIV infection within different geographic regions and populations in San Diego County, with the goal of demonstrating that early use of HIV treatment can reduce the number of new infections in our community. At the study visi...
What is the current status of trial NCT02528773?
This trial is currently completed. The enrollment target is 256 participants. The study started on 2014-09-09. Estimated completion is 2020-02-14.
What conditions does trial NCT02528773 study?
This clinical trial studies the following conditions: HIV.
Who is sponsoring clinical trial NCT02528773?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02528773 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.